BIOC - Biocept Inc News Story
$4.36 -0.0 -0.7%
Last Trade - 16/04/21
| Market Cap | £42.3m |
| Enterprise Value | £33.6m |
| Revenue | £19.9m |
| Position in Universe | 5515th / 6850 |
BRIEF-Biocept's Target Selector Liquid Biopsy Shows High Accuracy In Monitoring Metastatic Breast Cancer
Thu 10th December, 2020 1:40pm
Dec 10 (Reuters) - Biocept Inc BIOC.O :
* BIOCEPT INC - CO'S TARGET SELECTOR LIQUID BIOPSY
DEMONSTRATED
HIGH ACCURACY WHEN USED FOR MONITORING PROGRESSION OF METASTATIC
BREAST CANCER
Source text for Eikon: ID:nPnbwd79a
Further company coverage: BIOC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biocept Inc
See all news
